{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:33:54Z","timestamp":1791329634299,"version":"4.3.1"},"reference-count":260,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,2]]},"DOI":"10.7759\/cureus.33274","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:06:18Z","timestamp":1672704378000},"source":"Crossref","is-referenced-by-count":11,"title":["Relevant Dermatoses Among U.S. Military Service Members: An Operational Review of Management Strategies and Telemedicine Utilization"],"prefix":"10.7759","author":[{"given":"Gehan A","family":"Pendlebury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Oro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstyn","family":"Ludlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Merideth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED.173.9.882","article-title":"Evaluation of dermatologic conditions by primary care providers in deployed military settings","volume":"173","author":"Arnold JG","year":"2008","unstructured":"Arnold JG, Michener MD. Evaluation of dermatologic conditions by primary care providers in deployed military settings. Mil Med. 2008, 173:882-8. 10.7205\/MILMED.173.9.882","journal-title":"Mil Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-14-00240","article-title":"A review of skin conditions in modern warfare and peacekeeping operations","volume":"180","author":"Gelman AB","year":"2015","unstructured":"Gelman AB, Norton SA, Valdes-Rodriguez R, Yosipovitch G. A review of skin conditions in modern warfare and peacekeeping operations. Mil Med. 2015, 180:32-7. 10.7205\/MILMED-D-14-00240","journal-title":"Mil Med"},{"key":"ref3","article-title":"Treatment consideration for US military members with skin disease","volume":"103","author":"Burke KR","year":"2019","unstructured":"Burke KR, Larrymore DC, Cho S. Treatment consideration for US military members with skin disease. Cutis. 2019, 103:329-32.","journal-title":"Cutis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.11.062","article-title":"Skin cancer in the military: a systematic review of melanoma and nonmelanoma skin cancer incidence, prevention, and screening among active duty and veteran personnel","volume":"78","author":"Riemenschneider K","year":"2018","unstructured":"Riemenschneider K, Liu J, Powers JG. Skin cancer in the military: a systematic review of melanoma and nonmelanoma skin cancer incidence, prevention, and screening among active duty and veteran personnel. J Am Acad Dermatol. 2018, 78:1185-92. 10.1016\/j.jaad.2017.11.062","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5070\/D3232033983","article-title":"The Department of Defense: pioneers of early teledermatology","volume":"23","author":"Rosenbaum BE","year":"2017","unstructured":"Rosenbaum BE, Campion CH, Cohen JM, Latkowski JA. The Department of Defense: pioneers of early teledermatology. Dermatol Online J. 2017, 23:10.5070\/D3232033983","journal-title":"Dermatol Online J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s13671-021-00330-9","article-title":"Teledermatology in military settings","volume":"10","author":"Schafrank LA","year":"2021","unstructured":"Schafrank LA, Falkner RC, Lam TK, Meyerle JH. Teledermatology in military settings. Curr Derm Rep. 2021, 10:33-9. 10.1007\/s13671-021-00330-9","journal-title":"Curr Derm Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.12.043","article-title":"The burden of skin disease in the United States","volume":"76","author":"Lim HW","year":"2017","unstructured":"Lim HW, Collins SA, Resneck JS Jr, et al.. The burden of skin disease in the United States. J Am Acad Dermatol. 2017, 76:958-972.e2. 10.1016\/j.jaad.2016.12.043","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v1.i7.208","article-title":"Dermatology in the military field: what physicians should know?","volume":"1","author":"Chong WS","year":"2013","unstructured":"Chong WS. Dermatology in the military field: what physicians should know?. World J Clin Cases. 2013, 1:208-11. 10.12998\/wjcc.v1.i7.208","journal-title":"World J Clin Cases"},{"key":"ref9","article-title":"Overview of international teledermatology","volume":"6","author":"Desai B","year":"2010","unstructured":"Desai B, McKoy K, Kovarik C. Overview of international teledermatology. Pan Afr Med J. 2010, 6:3.","journal-title":"Pan Afr Med J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2015.08.001","article-title":"Bacterial skin infections","volume":"42","author":"Ibrahim F","year":"2015","unstructured":"Ibrahim F, Khan T, Pujalte GG. Bacterial skin infections. Prim Care. 2015, 42:485-99. 10.1016\/j.pop.2015.08.001","journal-title":"Prim Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/jramc-2013-000134","article-title":"Skin and soft tissue infections in the military","volume":"159","author":"Lamb L","year":"2013","unstructured":"Lamb L, Morgan M. Skin and soft tissue infections in the military. J R Army Med Corps. 2013, 159:215-23. 10.1136\/jramc-2013-000134","journal-title":"J R Army Med Corps"},{"key":"ref12","article-title":"Skin and soft tissue infections, active component, U.S. Armed Forces, January 2016-September 2020","volume":"28","author":"Stahlman S","year":"2021","unstructured":"Stahlman S, Williams VF, Oh GT, Tribble DR, Millar EV. Skin and soft tissue infections, active component, U.S. Armed Forces, January 2016-September 2020. MSMR. 2021, 28:27-38.","journal-title":"MSMR"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu166","article-title":"Hygiene strategies to prevent methicillin-resistant Staphylococcus aureus skin and soft tissue infections: a cluster-randomized controlled trial among high-risk military trainees","volume":"58","author":"Ellis MW","year":"2014","unstructured":"Ellis MW, Schlett CD, Millar EV, et al.. Hygiene strategies to prevent methicillin-resistant Staphylococcus aureus skin and soft tissue infections: a cluster-randomized controlled trial among high-risk military trainees. Clin Infect Dis. 2014, 58:1540-8. 10.1093\/cid\/ciu166","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1134-2","article-title":"Erysipelas, a large retrospective study of aetiology and clinical presentation","volume":"15","author":"Bl\u00e4ckberg A","year":"2015","unstructured":"Bl\u00e4ckberg A, Trell K, Rasmussen M. Erysipelas, a large retrospective study of aetiology and clinical presentation. BMC Infect Dis. 2015, 15:402. 10.1186\/s12879-015-1134-2","journal-title":"BMC Infect Dis"},{"key":"ref15","article-title":"Erysipelas","author":"Michael Y","year":"2022","unstructured":"Michael Y, Shaukat NM. Erysipelas. StatPearls Publishing, Treasure Island, USA; 2022."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2018.05.004","article-title":"Skin infections","volume":"45","author":"Clebak KT","year":"2018","unstructured":"Clebak KT, Malone MA. Skin infections. Prim Care. 2018, 45:433-54. 10.1016\/j.pop.2018.05.004","journal-title":"Prim Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3109\/1040841X.2012.682051","article-title":"First step in the differential diagnosis of folliculitis: cytology","volume":"39","author":"Durdu M","year":"2013","unstructured":"Durdu M, Ilkit M. First step in the differential diagnosis of folliculitis: cytology. Crit Rev Microbiol. 2013, 39:9-25. 10.3109\/1040841X.2012.682051","journal-title":"Crit Rev Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2014.02.009","article-title":"Facial bacterial infections: folliculitis","volume":"32","author":"Laureano AC","year":"2014","unstructured":"Laureano AC, Schwartz RA, Cohen PJ. Facial bacterial infections: folliculitis. Clin Dermatol. 2014, 32:711-14. 10.1016\/j.clindermatol.2014.02.009","journal-title":"Clin Dermatol"},{"key":"ref19","article-title":"Military grooming standards and their impact on skin diseases of the head and neck","volume":"102","author":"Weiss AN","year":"2018","unstructured":"Weiss AN, Arballo OM, Miletta NR, Wohltmann WE. Military grooming standards and their impact on skin diseases of the head and neck. Cutis. 2018, 102:328-33.","journal-title":"Cutis"},{"key":"ref20","article-title":"Diagnosis and treatment of impetigo","volume":"75","author":"Cole C","year":"2007","unstructured":"Cole C, Gazewood JD. Diagnosis and treatment of impetigo. Am Fam Physician. 2007, 75:859-64.","journal-title":"Am Fam Physician"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136789","article-title":"The global epidemiology of impetigo: a systematic review of the population prevalence of impetigo and pyoderma","volume":"10","author":"Bowen AC","year":"2015","unstructured":"Bowen AC, Mah\u00e9 A, Hay RJ, Andrews RM, Steer AC, Tong SY, Carapetis JR. The global epidemiology of impetigo: a systematic review of the population prevalence of impetigo and pyoderma. PLoS One. 2015, 10:e0136789. 10.1371\/journal.pone.0136789","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2011.01700.x","article-title":"Bacterial resistance and impetigo treatment trends: a review","volume":"29","author":"Bangert S","year":"2012","unstructured":"Bangert S, Levy M, Hebert AA. Bacterial resistance and impetigo treatment trends: a review. Pediatr Dermatol. 2012, 29:243-8. 10.1111\/j.1525-1470.2011.01700.x","journal-title":"Pediatr Dermatol"},{"key":"ref23","article-title":"Impetigo: diagnosis and treatment","volume":"90","author":"Hartman-Adams H","year":"2014","unstructured":"Hartman-Adams H, Banvard C, Juckett G.  Impetigo: diagnosis and treatment. Am Fam Physician. 2014, 90:229-35.","journal-title":"Am Fam Physician"},{"key":"ref24","article-title":"Impetigo (Nursing)","author":"Nardi NM","year":"2022","unstructured":"Nardi NM, Schaefer TJ, Espil MO. Impetigo (Nursing). StatPearls Publishing, Treasure Island, USA; 2022."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.11.021","article-title":"Burden, risk factors, and infectious complications of cellulitis and erysipelas in US adults and children in the emergency department setting","volume":"84","author":"Ren Z","year":"2021","unstructured":"Ren Z, Silverberg JI. Burden, risk factors, and infectious complications of cellulitis and erysipelas in US adults and children in the emergency department setting. J Am Acad Dermatol. 2021, 84:1496-503. 10.1016\/j.jaad.2020.11.021","journal-title":"J Am Acad Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.18-2-160","article-title":"Diagnosis and management of cellulitis","volume":"18","author":"Sullivan T","year":"2018","unstructured":"Sullivan T, de Barra E. Diagnosis and management of cellulitis. Clin Med J. 2018, 18:160-3. 10.7861\/clinmedicine.18-2-160","journal-title":"Clin Med J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.8825","article-title":"Cellulitis: a review","volume":"316","author":"Raff AB","year":"2016","unstructured":"Raff AB, Kroshinsky D. Cellulitis: a review. JAMA. 2016, 316:325-37. 10.1001\/jama.2016.8825","journal-title":"JAMA"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2020.12.003","article-title":"Managing a cutaneous abscess in the emergency department","volume":"78","author":"Schmitz GR","year":"2021","unstructured":"Schmitz GR, Gottlieb M. Managing a cutaneous abscess in the emergency department. Ann Emerg Med. 2021, 78:44-8. 10.1016\/j.annemergmed.2020.12.003","journal-title":"Ann Emerg Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz977","article-title":"National trends in incidence of purulent skin and soft tissue infections in patients presenting to ambulatory and emergency department settings, 2000-2015","volume":"70","author":"Fritz SA","year":"2020","unstructured":"Fritz SA, Shapiro DJ, Hersh AL. National trends in incidence of purulent skin and soft tissue infections in patients presenting to ambulatory and emergency department settings, 2000-2015. Clin Infect Dis. 2020, 70:2715-8. 10.1093\/cid\/ciz977","journal-title":"Clin Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-020-01941-9","article-title":"Incision and drainage of cutaneous abscess with or without cavity packing: a systematic review, meta-analysis, and trial sequential analysis of randomised controlled trials","volume":"406","author":"Mohamedahmed AY","year":"2021","unstructured":"Mohamedahmed AY, Zaman S, Stonelake S, Ahmad AN, Datta U, Hajibandeh S, Hajibandeh S. Incision and drainage of cutaneous abscess with or without cavity packing: a systematic review, meta-analysis, and trial sequential analysis of randomised controlled trials. Langenbecks Arch Surg. 2021, 406:981-91. 10.1007\/s00423-020-01941-9","journal-title":"Langenbecks Arch Surg"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2013.08.003","article-title":"Necrotizing fasciitis: eight-year experience and literature review","volume":"18","author":"Wang JM","year":"2014","unstructured":"Wang JM, Lim HK. Necrotizing fasciitis: eight-year experience and literature review. Braz J Infect Dis. 2014, 18:137-43. 10.1016\/j.bjid.2013.08.003","journal-title":"Braz J Infect Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.9371","article-title":"Early diagnosis of necrotizing fasciitis","volume":"101","author":"Goh T","year":"2014","unstructured":"Goh T, Goh LG, Ang CH, Wong CH. Early diagnosis of necrotizing fasciitis. Br J Surg. 2014, 101:e119-25. 10.1002\/bjs.9371","journal-title":"Br J Surg"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.49.2964","article-title":"Necrotizing fasciitis","volume":"49","author":"Shimizu T","year":"2010","unstructured":"Shimizu T, Tokuda Y. Necrotizing fasciitis. Intern Med. 2010, 49:1051-7. 10.2169\/internalmedicine.49.2964","journal-title":"Intern Med"},{"key":"ref34","unstructured":"Impetigo. diagnosis and treatment. (2021). Accessed: May 24, 2022: https:\/\/www.aad.org\/public\/diseases\/a-z\/impetigo-treatment."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2014.00036","article-title":"Current concepts in the management of necrotizing fasciitis","volume":"1","author":"Misiakos EP","year":"2014","unstructured":"Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A. Current concepts in the management of necrotizing fasciitis. Front Surg. 2014, 1:36. 10.3389\/fsurg.2014.00036","journal-title":"Front Surg"},{"key":"ref36","unstructured":"Epidemiology & risk factors. (2020). Accessed. May 24, 2022: https:\/\/www.cdc.gov\/parasites\/leishmaniasis\/epi.html."},{"key":"ref37","unstructured":"Leishmaniasis. Accessed. May 24, 2022: https:\/\/www.who.int\/health-topics\/leishmaniasis."},{"key":"ref38","article-title":"Efficacy of permethrin treated bed nets against leishmania major infected sand flies","author":"Rowland T","year":"2015","unstructured":"Rowland T, Davidson SA, Kobylinski K, Menses C, Rowton E. Efficacy of permethrin treated bed nets against leishmania major infected sand flies. US Army Med Dep J. 2015, 10-5.","journal-title":"US Army Med Dep J"},{"key":"ref39","article-title":"Incident diagnoses of leishmaniasis, active and reserve components, U.S. Armed Forces, 2001-2016","volume":"24","author":"Stahlman S","year":"2017","unstructured":"Stahlman S, Williams VF, Taubman SB. Incident diagnoses of leishmaniasis, active and reserve components, U.S. Armed Forces, 2001-2016. MSMR. 2017, 24:2-7.","journal-title":"MSMR"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt BL","year":"1999","unstructured":"Herwaldt BL. Leishmaniasis. Lancet. 1999, 354:1191-9. 10.1016\/S0140-6736(98)10178-2","journal-title":"Lancet"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-015-0114-z","article-title":"Cutaneous leishmaniasis: recent developments in diagnosis and management","volume":"16","author":"de Vries HJ","year":"2015","unstructured":"de Vries HJ, Reedijk SH, Schallig HD. Cutaneous leishmaniasis: recent developments in diagnosis and management. Am J Clin Dermatol. 2015, 16:99-109. 10.1007\/s40257-015-0114-z","journal-title":"Am J Clin Dermatol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1179\/2047773213Y.0000000098","article-title":"Three Leishmania\/L. species - L. infantum, L. major, L. tropica - as causative agents of mucosal leishmaniasis in Iran","volume":"107","author":"Shirian S","year":"2013","unstructured":"Shirian S, Oryan A, Hatam GR, Daneshbod Y. Three Leishmania\/L. species - L. infantum, L. major, L. tropica - as causative agents of mucosal leishmaniasis in Iran. Pathog Glob Health. 2013, 107:267-72. 10.1179\/2047773213Y.0000000098","journal-title":"Pathog Glob Health"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hch127","article-title":"New world mucosal and cutaneous leishmaniasis: an emerging health problem among British travellers","volume":"97","author":"Lawn SD","year":"2004","unstructured":"Lawn SD, Whetham J, Chiodini PL, Kanagalingam J, Watson J, Behrens RH, Lockwood DN. New world mucosal and cutaneous leishmaniasis: an emerging health problem among British travellers. QJM. 2004, 97:781-8. 10.1093\/qjmed\/hch127","journal-title":"QJM"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.6313","article-title":"Nonconventional opponents: a review of malaria and leishmaniasis among United States Armed Forces","volume":"7","author":"Beiter KJ","year":"2019","unstructured":"Beiter KJ, Wentlent ZJ, Hamouda AR, Thomas BN. Nonconventional opponents: a review of malaria and leishmaniasis among United States Armed Forces. PeerJ. 2019, 7:e6313. 10.7717\/peerj.6313","journal-title":"PeerJ"},{"key":"ref45","unstructured":"Leishmania Rapid Diagnostic Device Receives FDA clearance. (2014). Accessed. May 24, 2022: https:\/\/www.army.mil\/article\/138447\/leishmania_rapid_diagnostic_device_receives_fda_clearance."},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S146521","article-title":"Leishmaniasis in humans: drug or vaccine therapy?","volume":"12","author":"Ghorbani M","year":"2018","unstructured":"Ghorbani M, Farhoudi R. Leishmaniasis in humans: drug or vaccine therapy?. Drug Des Devel Ther. 2018, 12:25-40. 10.2147\/DDDT.S146521","journal-title":"Drug Des Devel Ther"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152805","article-title":"Personal Protection of Permethrin-Treated Clothing against Aedes aegypti, the Vector of Dengue and Zika Virus, in the Laboratory","volume":"11","author":"Orsborne J","year":"2016","unstructured":"Orsborne J, DeRaedt Banks S, Hendy A, et al.. Personal Protection of Permethrin-Treated Clothing against Aedes aegypti, the Vector of Dengue and Zika Virus, in the Laboratory. PLoS One. 2016, 11:e0152805. 10.1371\/journal.pone.0152805","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.aogh.2017.10.015","article-title":"Leishmaniasis: who uses personal protection among military personnel in colombia?","volume":"83","author":"Gonz\u00e1lez AM","year":"2017","unstructured":"Gonz\u00e1lez AM, Sol\u00eds-Soto MT, Radon K. Leishmaniasis: who uses personal protection among military personnel in colombia?. Ann Glob Health. 2017, 83:519-23. 10.1016\/j.aogh.2017.10.015","journal-title":"Ann Glob Health"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw670","article-title":"Diagnosis and treatment of leishmaniasis: Clinical practice guidelines by the infectious diseases society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"63","author":"Aronson N","year":"2016","unstructured":"Aronson N, Herwaldt BL, Libman M, et al.. Diagnosis and treatment of leishmaniasis: Clinical practice guidelines by the infectious diseases society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2016, 63:e202-64. 10.1093\/cid\/ciw670","journal-title":"Clin Infect Dis"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/s0924-8579(99)00133-8","article-title":"A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis","volume":"13","author":"Yardley V","year":"2000","unstructured":"Yardley V, Croft SL. A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis. Int J Antimicrob Agents. 2000, 13:243-8. 10.1016\/s0924-8579(99)00133-8","journal-title":"Int J Antimicrob Agents"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1086\/517634","article-title":"Failure of amphotericin B lipid complex in the treatment of cutaneous leishmaniasis","volume":"26","author":"Wortmann GW","year":"1998","unstructured":"Wortmann GW, Fraser SL, Aronson NE, Davis C, Miller RS, Jackson JD, Oster CN. Failure of amphotericin B lipid complex in the treatment of cutaneous leishmaniasis. Clin Infect Dis. 1998, 26:1006-7. 10.1086\/517634","journal-title":"Clin Infect Dis"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1086\/424845","article-title":"A US Soldier Who Returned from Iraq with Nonhealing Sores","volume":"39","author":"Mackowiak PA","year":"2004","unstructured":"Mackowiak PA. A US Soldier Who Returned from Iraq with Nonhealing Sores. Clinical Infectious Diseases. 2004, 39:1008-9. 10.1086\/424845","journal-title":"Clinical Infectious Diseases"},{"key":"ref53","unstructured":"Dermatological presentations in military conscripts. Accessed. May 24, 2022: https:\/\/military-medicine.com\/article\/3174-dermatological-presentations-in-military-conscripts.html."},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.178099","article-title":"Management of tinea corporis, tinea cruris, and tinea pedis: a comprehensive review","volume":"7","author":"Sahoo AK","year":"2016","unstructured":"Sahoo AK, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis: a comprehensive review. Indian Dermatol Online J. 2016, 7:77-86. 10.4103\/2229-5178.178099","journal-title":"Indian Dermatol Online J"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.31128\/AJGP-05-19-4930","article-title":"Superficial fungal infections","volume":"48","author":"Kovitwanichkanont T","year":"2019","unstructured":"Kovitwanichkanont T, Chong AH. Superficial fungal infections. Aust J Gen Pract. 2019, 48:706-11. 10.31128\/AJGP-05-19-4930","journal-title":"Aust J Gen Pract"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3109\/1040841X.2013.856853","article-title":"Tinea pedis: the etiology and global epidemiology of a common fungal infection","volume":"41","author":"Ilkit M","year":"2015","unstructured":"Ilkit M, Durdu M. Tinea pedis: the etiology and global epidemiology of a common fungal infection. Crit Rev Microbiol. 2015, 41:374-88. 10.3109\/1040841X.2013.856853","journal-title":"Crit Rev Microbiol"},{"key":"ref57","article-title":"Diagnosis and management of tinea infections","volume":"90","author":"Ely JW","year":"2014","unstructured":"Ely JW, Rosenfeld S, Seabury Stone M. Diagnosis and management of tinea infections. Am Fam Physician. 2014, 90:702-10.","journal-title":"Am Fam Physician"},{"key":"ref58","article-title":"Efficacy of antifungal cream versus powder in the treatment of fungal foot skin infection and unpleasant foot odor at medial department of thai naval rating school","volume":"49","author":"Ongsri P","year":"2018","unstructured":"Ongsri P, Bunyaratavej S, Leeyaphan C, Pattanaprichakul P, Ongmahutmongkol P, Ariyatanasuporn N, Kulthanan K. Efficacy of antifungal cream versus powder in the treatment of fungal foot skin infection and unpleasant foot odor at medial department of thai naval rating school. Southeast Asian J Trop Med Public Health. 2018, 49:7.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1002\/ett.3963","article-title":"An internet of health things-driven deep learning framework for detection and classification of skin cancer using transfer learning","volume":"32","author":"Khamparia A","year":"2021","unstructured":"Khamparia A, Singh PK, Rani P, Samanta D, Khanna A, Bhushan B. An internet of health things-driven deep learning framework for detection and classification of skin cancer using transfer learning. Transactions on Emerging Telecommunications Technologies. 2021, 32:3963. 10.1002\/ett.3963","journal-title":"Transactions on Emerging Telecommunications Technologies"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-016-0165-y","article-title":"Skin cancer: epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches","volume":"7","author":"Apalla Z","year":"2017","unstructured":"Apalla Z, Nashan D, Weller RB, Castellsagu\u00e9 X. Skin cancer: epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches. Dermatol Ther (Heidelb). 2017, 7:5-19. 10.1007\/s13555-016-0165-y","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref61","unstructured":"What to look for. ABCDEs of melanoma. Accessed: May 24, 2022: https:\/\/www.aad.org\/public\/diseases\/skin-cancer\/find\/at-risk\/abcdes."},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04296.x","article-title":"Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions","volume":"25","author":"Bonerandi JJ","year":"2011","unstructured":"Bonerandi JJ, Beauvillain C, Caquant L, et al.. Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. J Eur Acad Dermatol Venereol. 2011, 25:1-51. 10.1111\/j.1468-3083.2011.04296.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-014-0049-y","article-title":"Actinic keratosis: rationale and management","volume":"4","author":"Dodds A","year":"2014","unstructured":"Dodds A, Chia A, Shumack S. Actinic keratosis: rationale and management. Dermatol Ther (Heidelb). 2014, 4:11-31. 10.1007\/s13555-014-0049-y","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.11.033","article-title":"Keratoacanthoma (KA): an update and review","volume":"74","author":"Kwiek B","year":"2016","unstructured":"Kwiek B, Schwartz RA. Keratoacanthoma (KA): an update and review. J Am Acad Dermatol. 2016, 74:1220-33. 10.1016\/j.jaad.2015.11.033","journal-title":"J Am Acad Dermatol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-33919-1_13","article-title":"Precursor lesions of skin cancer","author":"Segatto MM","year":"2018","unstructured":"Segatto MM, Botton EU. Precursor lesions of skin cancer. Dermatology in Public Health Environments: A Comprehensive Textbook. Bonamigo RR, Dornelles SI (ed): Springer International Publishing, Cham; 2018. 10.1007\/978-3-319-33919-1_13"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.4103\/jomfp.JOMFP_156_17","article-title":"Cutaneous horn: a mask to underlying malignancy","volume":"22","author":"Phulari RG","year":"2018","unstructured":"Phulari RG, Rathore R, Talegaon TP, Shah A. Cutaneous horn: a mask to underlying malignancy. J Oral Maxillofac Pathol. 2018, 22:S87-90. 10.4103\/jomfp.JOMFP_156_17","journal-title":"J Oral Maxillofac Pathol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(05)70067-X","article-title":"Evaluation and management of nonmelanoma skin cancer: the military perspective","volume":"17","author":"Welch ML","year":"1999","unstructured":"Welch ML, Anderson LL, Grabski WJ. Evaluation and management of nonmelanoma skin cancer: the military perspective. Dermatologic Clinics. 1999, 17:19-28. 10.1016\/S0733-8635(05)70067-X","journal-title":"Dermatologic Clinics"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.11.001","article-title":"Skin cancer and new treatment perspectives: a review","volume":"357","author":"Sim\u00f5es MC","year":"2015","unstructured":"Sim\u00f5es MC, Sousa JJ, Pais AA. Skin cancer and new treatment perspectives: a review. Cancer Lett. 2015, 357:8-42. 10.1016\/j.canlet.2014.11.001","journal-title":"Cancer Lett"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.5120\/5817-8129","article-title":"Automatic detection of melanoma skin cancer using texture analysis","volume":"42","author":"Sheha MA","year":"2012","unstructured":"Sheha MA, Mabrouk MS, Sharawy A. Automatic detection of melanoma skin cancer using texture analysis. Int J Comput Appl. 2012, 42:22-26. 10.5120\/5817-8129","journal-title":"Int J Comput Appl"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14340","article-title":"Are military personnel at a more risk for skin cancers?","volume":"33","author":"Durmishi A","year":"2020","unstructured":"Durmishi A, Fida M, Hoxha S, Naqo X, Bardhi B, Xhelili M, Vasili E. Are military personnel at a more risk for skin cancers?. Dermatol Ther. 2020, 33:e14340. 10.1111\/dth.14340","journal-title":"Dermatol Ther"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.12788\/cutis.0153","article-title":"Skin cancer in the US military","volume":"107","author":"Gall R","year":"2021","unstructured":"Gall R, Bongiorno M, Handfield K. Skin cancer in the US military. Cutis. 2021, 107:29-33. 10.12788\/cutis.0153","journal-title":"Cutis"},{"key":"ref72","article-title":"Skin cancer in military pilots: a special population with special risk factors","volume":"100","author":"Wilkison BD","year":"2017","unstructured":"Wilkison BD, Wong EB. Skin cancer in military pilots: a special population with special risk factors. Cutis. 2017, 100:218-20.","journal-title":"Cutis"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15957","article-title":"The genetic and epigenetic basis of distinct melanoma types","volume":"48","author":"Oba J","year":"2021","unstructured":"Oba J, Woodman SE. The genetic and epigenetic basis of distinct melanoma types. J Dermatol. 2021, 48:925-39. 10.1111\/1346-8138.15957","journal-title":"J Dermatol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2013.09.003","article-title":"Outcomes and prognostic factors in superficial spreading melanoma","volume":"206","author":"Egger ME","year":"2013","unstructured":"Egger ME, Stepp LO, Callender GG, et al.. Outcomes and prognostic factors in superficial spreading melanoma. Am J Surg. 2013, 206:861-8. 10.1016\/j.amjsurg.2013.09.003","journal-title":"Am J Surg"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212281","article-title":"Diagnosis and management of lentigo maligna: a review","volume":"4","author":"Kasprzak JM","year":"2015","unstructured":"Kasprzak JM, Xu YG. Diagnosis and management of lentigo maligna: a review. Drugs Context. 2015, 4:212281. 10.7573\/dic.212281","journal-title":"Drugs Context"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10621.x","article-title":"Blue-black rule: a simple dermoscopic clue to recognize pigmented nodular melanoma","volume":"165","author":"Argenziano G","year":"2011","unstructured":"Argenziano G, Longo C, Cameron A, et al.. Blue-black rule: a simple dermoscopic clue to recognize pigmented nodular melanoma. Br J Dermatol. 2011, 165:1251-5. 10.1111\/j.1365-2133.2011.10621.x","journal-title":"Br J Dermatol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1586\/17469872.3.5.569","article-title":"Current concepts of metastasis in melanoma","volume":"3","author":"Zbytek B","year":"2008","unstructured":"Zbytek B, Carlson JA, Granese J, Ross J, Mihm MC Jr, Slominski A. Current concepts of metastasis in melanoma. Expert Rev Dermatol. 2008, 3:569-85. 10.1586\/17469872.3.5.569","journal-title":"Expert Rev Dermatol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.238","article-title":"Skin cancer risk factors and preventative behaviors among United States military veterans deployed to Iraq and Afghanistan","volume":"135","author":"Powers JG","year":"2015","unstructured":"Powers JG, Patel NA, Powers EM, Mayer JE, Stricklin GP, Geller AC. Skin cancer risk factors and preventative behaviors among United States military veterans deployed to Iraq and Afghanistan. J Invest Dermatol. 2015, 135:2871-3. 10.1038\/jid.2015.238","journal-title":"J Invest Dermatol"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.2344","article-title":"Sunscreen product performance and other determinants of consumer preferences","volume":"152","author":"Xu S","year":"2016","unstructured":"Xu S, Kwa M, Agarwal A, Rademaker A, Kundu RV. Sunscreen product performance and other determinants of consumer preferences. JAMA Dermatol. 2016, 152:920-7. 10.1001\/jamadermatol.2016.2344","journal-title":"JAMA Dermatol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12631","article-title":"Nicotinamide for skin cancer chemoprevention","volume":"58","author":"Damian DL","year":"2017","unstructured":"Damian DL. Nicotinamide for skin cancer chemoprevention. Australas J Dermatol. 2017, 58:174-80. 10.1111\/ajd.12631","journal-title":"Australas J Dermatol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1159\/000520592","article-title":"Defining the validity of skin self-examination as a screening test for the detection of suspicious pigmented lesions: a meta-analysis of diagnostic test accuracy","volume":"238","author":"Jiyad Z","year":"2022","unstructured":"Jiyad Z, Plasmeijer EI, Keegan S, Samarasinghe V, Green AC, Akhras V. Defining the validity of skin self-examination as a screening test for the detection of suspicious pigmented lesions: a meta-analysis of diagnostic test accuracy. Dermatology. 2022, 238:640-8. 10.1159\/000520592","journal-title":"Dermatology"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.0302a05","article-title":"Mobile teledermoscopy-there's an app for that!","volume":"3","author":"B\u00f6rve A","year":"2013","unstructured":"B\u00f6rve A, Terstappen K, Sandberg C, Paoli J. Mobile teledermoscopy-there's an app for that!. Dermatol Pract Concept. 2013, 3:41-8. 10.5826\/dpc.0302a05","journal-title":"Dermatol Pract Concept"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(20)30001-7","article-title":"Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trial","volume":"2","author":"Janda M","year":"2020","unstructured":"Janda M, Horsham C, Vagenas D, et al.. Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trial. Lancet: Digit Health. 2020, 2:129-37. 10.1016\/S2589-7500(20)30001-7","journal-title":"Lancet: Digit Health"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.10.007","article-title":"Guidelines of care for the management of cutaneous squamous cell carcinoma","volume":"78","author":"Kim JY","year":"2018","unstructured":"Kim JY, Kozlow JH, Mittal B, Moyer J, Olenecki T, Rodgers P. Guidelines of care for the management of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2018, 78:560-78. 10.1016\/j.jaad.2017.10.007","journal-title":"J Am Acad Dermatol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.08.055","article-title":"Guidelines of care for the management of primary cutaneous melanoma","volume":"80","author":"Swetter SM","year":"2019","unstructured":"Swetter SM, Tsao H, Bichakjian CK, et al.. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2019, 80:208-50. 10.1016\/j.jaad.2018.08.055","journal-title":"J Am Acad Dermatol"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1111\/all.13397","article-title":"The EAACI\/GA\u00b2LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria","volume":"73","author":"Zuberbier T","year":"2018","unstructured":"Zuberbier T, Aberer W, Asero R, et al.. The EAACI\/GA\u00b2LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018, 73:1393-414. 10.1111\/all.13397","journal-title":"Allergy"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.01.020","article-title":"Urticaria: a comprehensive review\u2014epidemiology, diagnosis, and work-up","volume":"79","author":"Antia C","year":"2018","unstructured":"Antia C, Baquerizo K, Korman A, Bernstein JA, Alikhan A. Urticaria: a comprehensive review\u2014epidemiology, diagnosis, and work-up. J Am Acad Dermatol. 2018, 79:599-614. 10.1016\/j.jaad.2018.01.020","journal-title":"J Am Acad Dermatol"},{"key":"ref88","article-title":"Acute and chronic urticaria: evaluation and treatment","volume":"95","author":"Schaefer P","year":"2017","unstructured":"Schaefer P. Acute and chronic urticaria: evaluation and treatment. Am Fam Physician. 2017, 95:717-24.","journal-title":"Am Fam Physician"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.12441","article-title":"Urticaria","volume":"12","author":"Wedi B","year":"2014","unstructured":"Wedi B, Wieczorek D, Raap U, Kapp A. Urticaria. J German Soc Dermatol. 2014, 12:997-1009. 10.1111\/ddg.12441","journal-title":"J German Soc Dermatol"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-68617-2","article-title":"","year":"2020","unstructured":"Kanerva\u2019s Occupational Dermatology. John SM, Johansen JD, Rustemeyer T, Elsner P, Maibach HI (ed). Springer International Publishing, Cham; 2020. 10.1007\/978-3-319-68617-2"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.04.013","article-title":"Chronic spontaneous urticaria: the devil's itch","volume":"6","author":"Saini SS","year":"2018","unstructured":"Saini SS, Kaplan AP. Chronic spontaneous urticaria: the devil's itch. J Allergy Clin Immunol Pract. 2018, 6:1097-106. 10.1016\/j.jaip.2018.04.013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref92","article-title":"Clinical practice guideline for diagnosis and management of urticaria","volume":"34","author":"Kulthanan K","year":"2016","unstructured":"Kulthanan K, Tuchinda P, Chularojanamontri L, et al.. Clinical practice guideline for diagnosis and management of urticaria. Asian Pac J Allergy Immunol. 2016, 34:190-200.","journal-title":"Asian Pac J Allergy Immunol"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-17-00047","article-title":"The use of apremilast to treat psoriasis during deployment","volume":"182","author":"Rosenberg A","year":"2017","unstructured":"Rosenberg A, Meyerle J. The use of apremilast to treat psoriasis during deployment. Mil Med. 2017, 182:1628-31. 10.7205\/MILMED-D-17-00047","journal-title":"Mil Med"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2011.08.004","article-title":"Contact dermatitis in the United States: epidemiology, economic impact, and workplace prevention","volume":"30","author":"Cashman MW","year":"2012","unstructured":"Cashman MW, Reutemann PA, Ehrlich A. Contact dermatitis in the United States: epidemiology, economic impact, and workplace prevention. Dermatol Clin. 2012, 30:87-98. 10.1016\/j.det.2011.08.004","journal-title":"Dermatol Clin"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1111\/j.1396-0296.2004.04031.x","article-title":"Treatment of irritant and allergic contact dermatitis","volume":"17","author":"Cohen DE","year":"2004","unstructured":"Cohen DE, Heidary N. Treatment of irritant and allergic contact dermatitis. Dermatol Ther. 2004, 17:334-40. 10.1111\/j.1396-0296.2004.04031.x","journal-title":"Dermatol Ther"},{"key":"ref96","article-title":"Contact dermatitis","author":"Litchman G","year":"2022","unstructured":"Litchman G, Nair PA, Atwater AR, Bhutta BS. Contact dermatitis. StatPearls Publishing, Treasure Island, USA; 2022."},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2007.00409.x","article-title":"Irritant contact dermatitis: a review","volume":"49","author":"Slodownik D","year":"2008","unstructured":"Slodownik D, Lee A, Nixon R. Irritant contact dermatitis: a review. Australas J Dermatol. 2008, 49:1-9. 10.1111\/j.1440-0960.2007.00409.x","journal-title":"Australas J Dermatol"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2011.11024","article-title":"Contact dermatitis in military personnel","volume":"22","author":"Dever TT","year":"2011","unstructured":"Dever TT, Walters M, Jacob S. Contact dermatitis in military personnel. Dermatitis. 2011, 22:313-9. 10.2310\/6620.2011.11024","journal-title":"Dermatitis"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12432","article-title":"European Society of Contact Dermatitis guideline for diagnostic patch testing: recommendations on best practice","volume":"73","author":"Johansen JD","year":"2015","unstructured":"Johansen JD, Aalto-Korte K, Agner T, et al.. European Society of Contact Dermatitis guideline for diagnostic patch testing: recommendations on best practice. Contact Dermatitis. 2015, 73:195-221. 10.1111\/cod.12432","journal-title":"Contact Dermatitis"},{"key":"ref100","unstructured":"National occupational research agenda. Allergic and irritant dermatitis. (1996). Accessed. June 5, 2022: https:\/\/www.cdc.gov\/niosh\/docs\/96-115\/diseas.html."},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-68617-2_172","article-title":"Military personnel","author":"Trattner A","year":"2020","unstructured":"Trattner A, Lazarov A, Ingber A. Military personnel. Kanerva\u2019s Occupational Dermatology. John SM, Johansen JD, Rustemeyer T, Elsner P, Maibach HI (ed): Springer International Publishing, Cham; 2020. 2127-35. 10.1007\/978-3-319-68617-2_172"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1999.tb06074.x","article-title":"Allergic contact dermatitis from military camouflage","volume":"40","author":"Goon AT","year":"1999","unstructured":"Goon AT, Ng PP, Ng SK. Allergic contact dermatitis from military camouflage. Contact Dermatitis. 1999, 40:290-1. 10.1111\/j.1600-0536.1999.tb06074.x","journal-title":"Contact Dermatitis"},{"key":"ref103","unstructured":"Eczema types. contact dermatitis diagnosis and treatment. (2020). Accessed: July 11, 2022: https:\/\/www.aad.org\/public\/diseases\/eczema\/types\/contact-dermatitis\/treatment."},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)90194-9","article-title":"Guidelines of care for contact dermatitis","volume":"32","author":"Drake LA","year":"1995","unstructured":"Drake LA, Dorner W, Goltz RW, et al.. Guidelines of care for contact dermatitis. J Am Acad Dermatol. 1995, 32:109-13. 10.1016\/0190-9622(95)90194-9","journal-title":"J Am Acad Dermatol"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.04.075","article-title":"A systematic review of contact dermatitis treatment and prevention","volume":"53","author":"Saary J","year":"2005","unstructured":"Saary J, Qureshi R, Palda V, DeKoven J, Pratt M, Skotnicki-Grant S, Holness L. A systematic review of contact dermatitis treatment and prevention. J Am Acad Dermatol. 2005, 53:845. 10.1016\/j.jaad.2005.04.075","journal-title":"J Am Acad Dermatol"},{"key":"ref106","unstructured":"NIOSH alert on work-related latex allergy recommends steps to reduce exposures. (2020). Accessed. June 5, 2022: https:\/\/www.cdc.gov\/niosh\/updates\/latexpr.html."},{"key":"ref107","article-title":"Diagnosis and management of contact dermatitis","volume":"82","author":"Usatine RP","year":"2010","unstructured":"Usatine RP, Riojas M. Diagnosis and management of contact dermatitis. Am Fam Physician. 2010, 82:249-55.","journal-title":"Am Fam Physician"},{"key":"ref108","article-title":"Atopic dermatitis: diagnosis and treatment","volume":"101","author":"Frazier W","year":"2020","unstructured":"Frazier W, Bhardwaj N. Atopic dermatitis: diagnosis and treatment. Am Fam Physician. 2020, 101:590-8.","journal-title":"Am Fam Physician"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.08.028","article-title":"Atopic dermatitis in America study: a\u00a0cross-sectional study examining the prevalence\u00a0and disease burden of atopic dermatitis in the US adult population","volume":"139","author":"Chiesa Fuxench ZC","year":"2019","unstructured":"Chiesa Fuxench ZC, Block JK, Boguniewicz M, et al.. Atopic dermatitis in America study: a\u00a0cross-sectional study examining the prevalence\u00a0and disease burden of atopic dermatitis in the US adult population. J Invest Dermatol. 2019, 139:583-90. 10.1016\/j.jid.2018.08.028","journal-title":"J Invest Dermatol"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2011.01027.x","article-title":"Atopic dermatitis: a disease of altered skin barrier and immune dysregulation","volume":"242","author":"Boguniewicz M","year":"2011","unstructured":"Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011, 242:233-46. 10.1111\/j.1600-065X.2011.01027.x","journal-title":"Immunol Rev"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2015.07.029","article-title":"Utilization of preventive health care in adults and children with eczema","volume":"50","author":"Strom MA","year":"2016","unstructured":"Strom MA, Silverberg JI. Utilization of preventive health care in adults and children with eczema. Am J Prev Med. 2016, 50:e33-44. 10.1016\/j.amepre.2015.07.029","journal-title":"Am J Prev Med"},{"key":"ref112","article-title":"Understanding psychological health in the military","author":"Committee on the Assessment of Resiliency and Prevention Programs for Mental and Behavioral Health in Service Members and Their Families;","year":"2014","unstructured":"Committee on the Assessment of Resiliency and Prevention Programs for Mental and Behavioral Health in Service Members and Their Families;, Board on the Health of Select Populations, Institute of Medicine. Understanding psychological health in the military. Preventing Psychological Disorders in Service Members and Their Families: An Assessment of Programs. Denning LA, Meisnere M, Warner KE (ed): National Academies Press, Washington, DC, USA; 2014."},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1016\/0952-7915(93)90112-6","article-title":"Role of IgE in atopic dermatitis","volume":"5","author":"Leung DY","year":"1993","unstructured":"Leung DY. Role of IgE in atopic dermatitis. Curr Opin Immunol. 1993, 5:956-62. 10.1016\/0952-7915(93)90112-6","journal-title":"Curr Opin Immunol"},{"key":"ref114","unstructured":"Atopic dermatitis clinical guideline. (2022). Accessed. June 5, 2022: https:\/\/www.aad.org\/member\/clinical-quality\/guidelines\/atopic-dermatitis."},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18643","article-title":"The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group","volume":"182","author":"Alexander H","year":"2020","unstructured":"Alexander H, Paller AS, Traidl-Hoffmann C, et al.. The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group. Br J Dermatol. 2020, 182:1331-42. 10.1111\/bjd.18643","journal-title":"Br J Dermatol"},{"key":"ref116","article-title":"Eczema herpeticum: a medical emergency","volume":"58","author":"Liaw FY","year":"2012","unstructured":"Liaw FY, Huang CF, Hsueh JT, Chiang CP. Eczema herpeticum: a medical emergency. Can Fam Physician. 2012, 58:1358-61.","journal-title":"Can Fam Physician"},{"key":"ref117","article-title":"Eczema Herpeticum","author":"Xiao A","year":"2022","unstructured":"Xiao A, Tsuchiya A. Eczema Herpeticum. StatPearls Publishing, Treasure Island, USA; 2022."},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.15.4.545-563.2002","article-title":"Atopic dermatitis and fungi","volume":"15","author":"Faergemann J","year":"2002","unstructured":"Faergemann J. Atopic dermatitis and fungi. Clin Microbiol Rev. 2002, 15:545-63. 10.1128\/CMR.15.4.545-563.2002","journal-title":"Clin Microbiol Rev"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.03.023","article-title":"Guidelines of care for the management of atopic dermatitis: section 2. management and treatment of atopic dermatitis with topical therapies","volume":"71","author":"Eichenfield LF","year":"2014","unstructured":"Eichenfield LF, Tom WL, Berger TG, et al.. Guidelines of care for the management of atopic dermatitis: section 2. management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014, 71:116-32. 10.1016\/j.jaad.2014.03.023","journal-title":"J Am Acad Dermatol"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-020-0777-9","article-title":"Pruritus in pediatric patients with atopic dermatitis: a multidisciplinary approach - summary document from an Italian expert group","volume":"46","author":"El Hachem M","year":"2020","unstructured":"El Hachem M, Di Mauro G, Rotunno R, et al.. Pruritus in pediatric patients with atopic dermatitis: a multidisciplinary approach - summary document from an Italian expert group. Ital J Pediatr. 2020, 46:11. 10.1186\/s13052-020-0777-9","journal-title":"Ital J Pediatr"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12645","article-title":"Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research","volume":"170","author":"Garritsen FM","year":"2014","unstructured":"Garritsen FM, Brouwer MW, Limpens J, Spuls PI. Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research. Br J Dermatol. 2014, 170:501-13. 10.1111\/bjd.12645","journal-title":"Br J Dermatol"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.03.030","article-title":"Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents","volume":"71","author":"Sidbury R","year":"2014","unstructured":"Sidbury R, Davis DM, Cohen DE, et al.. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014, 71:327-49. 10.1016\/j.jaad.2014.03.030","journal-title":"J Am Acad Dermatol"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15928","article-title":"Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement","volume":"178","author":"Drucker AM","year":"2018","unstructured":"Drucker AM, Eyerich K, de Bruin-Weller MS, et al.. Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement. Br J Dermatol. 2018, 178:768-75. 10.1111\/bjd.15928","journal-title":"Br J Dermatol"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S163814","article-title":"Treatment-resistant atopic dermatitis: challenges and solutions","volume":"12","author":"Johnson BB","year":"2019","unstructured":"Johnson BB, Franco AI, Beck LA, Prezzano JC. Treatment-resistant atopic dermatitis: challenges and solutions. Clin Cosmet Investig Dermatol. 2019, 12:181-92. 10.2147\/CCID.S163814","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.06.017","article-title":"Management of inadequate response and adverse effects to dupilumab in atopic dermatitis","volume":"86","author":"Narla S","year":"2022","unstructured":"Narla S, Silverberg JI, Simpson EL. Management of inadequate response and adverse effects to dupilumab in atopic dermatitis. J Am Acad Dermatol. 2022, 86:628-36. 10.1016\/j.jaad.2021.06.017","journal-title":"J Am Acad Dermatol"},{"key":"ref126","article-title":"Atopic dermatitis: a review of diagnosis and treatment","volume":"60","author":"Correale CE","year":"1999","unstructured":"Correale CE, Walker C, Murphy L, Craig TJ. Atopic dermatitis: a review of diagnosis and treatment. Am Fam Physician. 1999, 60:1191-8.","journal-title":"Am Fam Physician"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usy427","article-title":"Atopic Dermatitis and Implications for Military Service","volume":"184","author":"Jeter J","year":"2019","unstructured":"Jeter J, Bowen C. Atopic Dermatitis and Implications for Military Service. Mil Med. 2019, 184:e177-82. 10.1093\/milmed\/usy427","journal-title":"Mil Med"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: a brief overview","volume":"21","author":"Raharja A","year":"2021","unstructured":"Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clin Med (Lond). 2021, 21:170-3. 10.7861\/clinmed.2021-0257","journal-title":"Clin Med (Lond)"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184347","article-title":"Risk factors for the development of psoriasis","volume":"20","author":"Kamiya K","year":"2019","unstructured":"Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci. 2019, 20:4347. 10.3390\/ijms20184347","journal-title":"Int J Mol Sci"},{"key":"ref130","article-title":"Psoriasis and psoriatic arthritis overview","volume":"22","author":"Alan Menter MD","year":"2016","unstructured":"Alan Menter MD. Psoriasis and psoriatic arthritis overview. Am J Manag Care. 2016, 22:S216-24.","journal-title":"Am J Manag Care"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review","volume":"323","author":"Armstrong AW","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA. 2020, 323:1945-60. 10.1001\/jama.2020.4006","journal-title":"JAMA"},{"key":"ref132","article-title":"Diagnosis and management of psoriasis","volume":"63","author":"Kim WB","year":"2017","unstructured":"Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Physician. 2017, 63:278-85.","journal-title":"Can Fam Physician"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-008-0866-x","article-title":"An investigation of antistreptococcal antibody responses in guttate psoriasis","volume":"300","author":"Nahary L","year":"2008","unstructured":"Nahary L, Tamarkin A, Kayam N, et al.. An investigation of antistreptococcal antibody responses in guttate psoriasis. Arch Dermatol Res. 2008, 300:441-9. 10.1007\/s00403-008-0866-x","journal-title":"Arch Dermatol Res"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.008","article-title":"Diagnosis and classification of psoriasis","volume":"13","author":"Raychaudhuri SK","year":"2014","unstructured":"Raychaudhuri SK, Maverakis E, Raychaudhuri SP. Diagnosis and classification of psoriasis. Autoimmun Rev. 2014, 13:490-5. 10.1016\/j.autrev.2014.01.008","journal-title":"Autoimmun Rev"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek IM","year":"2017","unstructured":"Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017, 31:205-12. 10.1111\/jdv.13854","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3384","article-title":"Psoriasis and genetics","volume":"100","author":"Dand N","year":"2020","unstructured":"Dand N, Mahil SK, Capon F, Smith CH, Simpson MA, Barker JN. Psoriasis and genetics. Acta Derm Venereol. 2020, 100:adv00030. 10.2340\/00015555-3384","journal-title":"Acta Derm Venereol"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14032","article-title":"Stress and psoriasis","volume":"57","author":"Rousset L","year":"2018","unstructured":"Rousset L, Halioua B. Stress and psoriasis. Int J Dermatol. 2018, 57:1165-72. 10.1111\/ijd.14032","journal-title":"Int J Dermatol"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14139","article-title":"Pathogenesis of psoriasis and development of treatment","volume":"45","author":"Ogawa E","year":"2018","unstructured":"Ogawa E, Sato Y, Minagawa A, Okuyama R. Pathogenesis of psoriasis and development of treatment. J Dermatol. 2018, 45:264-72. 10.1111\/1346-8138.14139","journal-title":"J Dermatol"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.10.062","article-title":"Trends in incidence of adult-onset psoriasis over three decades: a population-based study","volume":"60","author":"Icen M","year":"2009","unstructured":"Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Maradit Kremers H. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol. 2009, 60:394-401. 10.1016\/j.jaad.2008.10.062","journal-title":"J Am Acad Dermatol"},{"key":"ref140","unstructured":"Psoriasis clinical guideline. (2022). Accessed. June 5, 2022: https:\/\/www.aad.org\/member\/clinical-quality\/guidelines\/psoriasis."},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.092194","article-title":"Cryotherapy with liquid nitrogen versus topical salicylic acid application for cutaneous warts in primary care: randomized controlled trial","volume":"182","author":"Bruggink SC","year":"2010","unstructured":"Bruggink SC, Gussekloo J, Berger MY, et al.. Cryotherapy with liquid nitrogen versus topical salicylic acid application for cutaneous warts in primary care: randomized controlled trial. CMAJ. 2010, 182:1624-30. 10.1503\/cmaj.092194","journal-title":"CMAJ"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.02.044","article-title":"Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies","volume":"82","author":"Menter A","year":"2020","unstructured":"Menter A, Gelfand JM, Connor C, et al.. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies. J Am Acad Dermatol. 2020, 82:1445-86. 10.1016\/j.jaad.2020.02.044","journal-title":"J Am Acad Dermatol"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.04.042","article-title":"Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy","volume":"81","author":"Elmets CA","year":"2019","unstructured":"Elmets CA, Lim HW, Stoff B, et al.. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy. J Am Acad Dermatol. 2019, 81:775-804. 10.1016\/j.jaad.2019.04.042","journal-title":"J Am Acad Dermatol"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.12788\/cutis.0231","article-title":"Apremilast uses and relevance to the military","volume":"107","author":"Hathaway NE","year":"2021","unstructured":"Hathaway NE, Lyford WH. Apremilast uses and relevance to the military. Cutis. 2021, 107:216-20. 10.12788\/cutis.0231","journal-title":"Cutis"},{"key":"ref145","article-title":"Wart","author":"Al Aboud AM","year":"2022","unstructured":"Al Aboud AM, Nigam PK. Wart. StatPearls Publishing, Treasure Island, USA; 2022."},{"key":"ref146","article-title":"Genital warts","author":"Leslie SW","year":"2022","unstructured":"Leslie SW, Sajjad H, Kumar S. Genital warts. StatPearls Publishing, Treasure Island, USA; 2022."},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1948.01520150119017","article-title":"Mosaic type of plantar wart, its characteristics and treatment","volume":"57","author":"Montgomery AH","year":"1948","unstructured":"Montgomery AH, Montgomery RM. Mosaic type of plantar wart, its characteristics and treatment. Arch Derm Syphilol. 1948, 57:397-9. 10.1001\/archderm.1948.01520150119017","journal-title":"Arch Derm Syphilol"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1007\/BF00510364","article-title":"Two anatomoclinical types of warts with plantar localization: specific cytopathogenic effects of papillomavirus. Type I (HPV-1) and type 2 (HPV-2)","volume":"274","author":"Laurent R","year":"1982","unstructured":"Laurent R, Kienzler JL, Croissant O, Orth G. Two anatomoclinical types of warts with plantar localization: specific cytopathogenic effects of papillomavirus. Type I (HPV-1) and type 2 (HPV-2). Arch Dermatol Res. 1982, 274:101-11. 10.1007\/BF00510364","journal-title":"Arch Dermatol Res"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.07.049","article-title":"Warts and all: human papillomavirus in primary immunodeficiencies","volume":"130","author":"Leiding JW","year":"2012","unstructured":"Leiding JW, Holland SM. Warts and all: human papillomavirus in primary immunodeficiencies. J Allergy Clin Immunol. 2012, 130:1030-48. 10.1016\/j.jaci.2012.07.049","journal-title":"J Allergy Clin Immunol"},{"key":"ref150","article-title":"Warts: overview","author":"Institute for Quality and Efficiency in Health","year":"2019","unstructured":"Institute for Quality and Efficiency in Health. Warts: overview. Cover of InformedHealth.org InformedHealth.org, Colonge, Germany; 2019."},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004332","article-title":"Initial misdiagnosis of melanoma located on the foot is associated with poorer prognosis","volume":"95","author":"Sondermann W","year":"2016","unstructured":"Sondermann W, Zimmer L, Schadendorf D, Roesch A, Klode J, Dissemond J. Initial misdiagnosis of melanoma located on the foot is associated with poorer prognosis. Medicine (Baltimore). 2016, 95:e4332. 10.1097\/MD.0000000000004332","journal-title":"Medicine (Baltimore)"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.1016\/s0095-4543(05)70204-9","article-title":"Cutaneous warts: diagnosis and treatment","volume":"27","author":"Plasencia JM","year":"2000","unstructured":"Plasencia JM. Cutaneous warts: diagnosis and treatment. Prim Care: Clin Office Pract. 2000, 27:423-34. 10.1016\/s0095-4543(05)70204-9","journal-title":"Prim Care: Clin Office Pract"},{"key":"ref153","unstructured":"Human papillomavirus (HPV) treatment and care. (2021). Accessed. July 30, 2022: https:\/\/www.cdc.gov\/std\/hpv\/treatment.htm."},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.1016\/s1067-2516(01)80039-9","article-title":"Combined cryotherapy\/70% salicylic acid treatment for plantar verrucae","volume":"40","author":"van Brederode RL","year":"2001","unstructured":"van Brederode RL, Engel ED. Combined cryotherapy\/70% salicylic acid treatment for plantar verrucae. J Foot Ankle Surg. 2001, 40:36-41. 10.1016\/s1067-2516(01)80039-9","journal-title":"J Foot Ankle Surg"},{"key":"ref155","article-title":"What are the treatment options for warts?","author":"Institute for Quality and Efficiency  in Health Care","year":"2019","unstructured":"Institute for Quality and Efficiency  in Health Care. What are the treatment options for warts? . InformedHealth.org, Cologne, Germany; 2019."},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000001023","article-title":"Pulsed Dye Laser Therapy in the Treatment of Warts: A Review of the Literature","volume":"43","author":"Veitch D","year":"2017","unstructured":"Veitch D, Kravvas G, Al-Niaimi F. Pulsed Dye Laser Therapy in the Treatment of Warts: A Review of the Literature. Dermatol Surg. 2017, 43:485-93. 10.1097\/DSS.0000000000001023","journal-title":"Dermatol Surg"},{"key":"ref157","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2011.606465","article-title":"Treatment of recalcitrant warts with the carbon dioxide laser using an excision technique","volume":"13","author":"Oni G","year":"2011","unstructured":"Oni G, Mahaffey PJ. Treatment of recalcitrant warts with the carbon dioxide laser using an excision technique. J Cosmet Laser Ther. 2011, 13:231-6. 10.3109\/14764172.2011.606465","journal-title":"J Cosmet Laser Ther"},{"key":"ref158","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.0803a03","article-title":"Cryotherapy versus CO2 laser in the treatment of plantar warts: a randomized controlled trial","volume":"8","author":"Boroujeni NH","year":"2018","unstructured":"Boroujeni NH, Handjani F. Cryotherapy versus CO2 laser in the treatment of plantar warts: a randomized controlled trial. Dermatol Pract Concept. 2018, 8:168-73. 10.5826\/dpc.0803a03","journal-title":"Dermatol Pract Concept"},{"key":"ref159","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13789","article-title":"Laser and light therapy for facial warts: a systematic review","volume":"30","author":"Maranda EL","year":"2016","unstructured":"Maranda EL, Lim VM, Nguyen AH, Nouri K. Laser and light therapy for facial warts: a systematic review. J Eur Acad Dermatol Venereol. 2016, 30:1700-7. 10.1111\/jdv.13789","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref160","doi-asserted-by":"publisher","DOI":"10.1016\/s0738-081x(96)00153-8","article-title":"Therapy of cutaneous warts","volume":"15","author":"Benton EC","year":"1997","unstructured":"Benton EC. Therapy of cutaneous warts. Clin Dermatol. 1997, 15:449-55. 10.1016\/s0738-081x(96)00153-8","journal-title":"Clin Dermatol"},{"key":"ref161","unstructured":"Monochloroacetic acid. Accessed. June 5, 2022: https:\/\/inchem.org\/documents\/pims\/chemical\/pim352.htm."},{"key":"ref162","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04066.x","article-title":"Guidelines for the management of cutaneous warts","volume":"144","author":"Sterling JC","year":"2001","unstructured":"Sterling JC, Handfield-Jones S, Hudson PM. Guidelines for the management of cutaneous warts. Br J Dermatol. 2001, 144:4-11. 10.1046\/j.1365-2133.2001.04066.x","journal-title":"Br J Dermatol"},{"key":"ref163","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.2001.018003249.x","article-title":"Raynaud phenomenon after treatment of verruca vulgaris of the sole with intralesional injection of bleomycin","volume":"18","author":"Vanhooteghem O","year":"2001","unstructured":"Vanhooteghem O, Richert B, de la Brassinne M. Raynaud phenomenon after treatment of verruca vulgaris of the sole with intralesional injection of bleomycin. Pediatr Dermatol. 2001, 18:249-51. 10.1046\/j.1525-1470.2001.018003249.x","journal-title":"Pediatr Dermatol"},{"key":"ref164","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-014-0093-5","article-title":"Imiquimod in the treatment of cutaneous warts: an evidence-based review","volume":"15","author":"Ahn CS","year":"2014","unstructured":"Ahn CS, Huang WW. Imiquimod in the treatment of cutaneous warts: an evidence-based review. Am J Clin Dermatol. 2014, 15:387-99. 10.1007\/s40257-014-0093-5","journal-title":"Am J Clin Dermatol"},{"key":"ref165","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2006.03138.x","article-title":"Topical zinc oxide vs. salicylic acid-lactic acid combination in the treatment of warts","volume":"46","author":"Khattar JA","year":"2007","unstructured":"Khattar JA, Musharrafieh UM, Tamim H, Hamadeh GN. Topical zinc oxide vs. salicylic acid-lactic acid combination in the treatment of warts. Int J Dermatol. 2007, 46:427-30. 10.1111\/j.1365-4632.2006.03138.x","journal-title":"Int J Dermatol"},{"key":"ref166","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2021.05.024","article-title":"The status of treatment for plantar warts in 2021: No definitive advancements in decades for a common dermatology disease","volume":"39","author":"Hekmatjah J","year":"2021","unstructured":"Hekmatjah J, Farshchian M, Grant-Kels JM, Mehregan D. The status of treatment for plantar warts in 2021: No definitive advancements in decades for a common dermatology disease. Clin Dermatol. 2021, 39:688-94. 10.1016\/j.clindermatol.2021.05.024","journal-title":"Clin Dermatol"},{"key":"ref167","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13811","article-title":"Treatment of common recalcitrant warts with topical formic acid","volume":"57","author":"Schianchi R","year":"2018","unstructured":"Schianchi R, Brena M, Veraldi S. Treatment of common recalcitrant warts with topical formic acid. Int J Dermatol. 2018, 57:e3-4. 10.1111\/ijd.13811","journal-title":"Int J Dermatol"},{"key":"ref168","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2007.02955.x","article-title":"Efficacy of 10% silver nitrate solution in the treatment of common warts: a placebo-controlled, randomized, clinical trial","volume":"46","author":"Ebrahimi S","year":"2007","unstructured":"Ebrahimi S, Dabiri N, Jamshidnejad E, Sarkari B. Efficacy of 10% silver nitrate solution in the treatment of common warts: a placebo-controlled, randomized, clinical trial. Int J Dermatol. 2007, 46:215-7. 10.1111\/j.1365-4632.2007.02955.x","journal-title":"Int J Dermatol"},{"key":"ref169","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1994.tb01011.x","article-title":"Treatment of plane warts by tretinoin-induced irritant reaction","volume":"33","author":"al Aboosi M","year":"1994","unstructured":"al Aboosi M. Treatment of plane warts by tretinoin-induced irritant reaction. Int J Dermatol. 1994, 33:826-7. 10.1111\/j.1365-4362.1994.tb01011.x","journal-title":"Int J Dermatol"},{"key":"ref170","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001781.pub3","article-title":"Topical treatments for cutaneous warts","author":"Kwok CS","year":"2012","unstructured":"Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2012, CD001781. 10.1002\/14651858.CD001781.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref171","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08947.x","article-title":"The treatment of viral warts with topical cidofovir 1%: our experience of seven paediatric patients","volume":"160","author":"Field S","year":"2009","unstructured":"Field S, Irvine AD, Kirby B. The treatment of viral warts with topical cidofovir 1%: our experience of seven paediatric patients. Br J Dermatol. 2009, 160:223-4. 10.1111\/j.1365-2133.2008.08947.x","journal-title":"Br J Dermatol"},{"key":"ref172","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2012.01477.x","article-title":"Intralesional cidofovir for the treatment of multiple and recalcitrant cutaneous viral warts","volume":"25","author":"Broganelli P","year":"2012","unstructured":"Broganelli P, Chiaretta A, Fragnelli B, Bernengo MG. Intralesional cidofovir for the treatment of multiple and recalcitrant cutaneous viral warts. Dermatol Ther. 2012, 25:468-71. 10.1111\/j.1529-8019.2012.01477.x","journal-title":"Dermatol Ther"},{"key":"ref173","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.190487","article-title":"Evolving role of immunotherapy in the treatment of refractory warts","volume":"7","author":"Thappa DM","year":"2016","unstructured":"Thappa DM, Chiramel MJ. Evolving role of immunotherapy in the treatment of refractory warts. Indian Dermatol Online J. 2016, 7:364-70. 10.4103\/2229-5178.190487","journal-title":"Indian Dermatol Online J"},{"key":"ref174","doi-asserted-by":"publisher","DOI":"10.7556\/jaoa.2018.024","article-title":"Plantar warts: epidemiology, pathophysiology, and clinical management","volume":"118","author":"Witchey DJ","year":"2018","unstructured":"Witchey DJ, Witchey NB, Roth-Kauffman MM, Kauffman MK. Plantar warts: epidemiology, pathophysiology, and clinical management. J Am Osteopath Assoc. 2018, 118:92-105. 10.7556\/jaoa.2018.024","journal-title":"J Am Osteopath Assoc"},{"key":"ref175","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.4.4.273","article-title":"An armamentarium of wart treatments","volume":"4","author":"Lipke MM","year":"2006","unstructured":"Lipke MM. An armamentarium of wart treatments. Clin Med Res. 2006, 4:273-93. 10.3121\/cmr.4.4.273","journal-title":"Clin Med Res"},{"key":"ref176","unstructured":"Warts. tips for managing. Accessed: June 5, 2022: https:\/\/www.aad.org\/public\/diseases\/a-z\/warts-self-care."},{"key":"ref177","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.156.10.971","article-title":"The efficacy of duct tape vs cryotherapy in the treatment of verruca vulgaris (the common wart)","volume":"156","author":"Focht DR 3rd","year":"2002","unstructured":"Focht DR 3rd, Spicer C, Fairchok MP. The efficacy of duct tape vs cryotherapy in the treatment of verruca vulgaris (the common wart). Arch Pediatr Adolesc Med. 2002, 156:971-4. 10.1001\/archpedi.156.10.971","journal-title":"Arch Pediatr Adolesc Med"},{"key":"ref178","article-title":"Acne vulgaris","volume":"2011","author":"Purdy S","year":"2011","unstructured":"Purdy S, de Berker D. Acne vulgaris. BMJ Clin Evid. 2011, 2011:1714.","journal-title":"BMJ Clin Evid"},{"key":"ref179","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60321-8","article-title":"Acne vulgaris","volume":"379","author":"Williams HC","year":"2012","unstructured":"Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012, 379:361-72. 10.1016\/S0140-6736(11)60321-8","journal-title":"Lancet"},{"key":"ref180","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62715-3","article-title":"Systematic review of the epidemiology of acne vulgaris","volume":"10","author":"Heng AH","year":"2020","unstructured":"Heng AH, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep. 2020, 10:5754. 10.1038\/s41598-020-62715-3","journal-title":"Sci Rep"},{"key":"ref181","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12149","article-title":"Epidemiology of acne vulgaris","volume":"168","author":"Bhate K","year":"2013","unstructured":"Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013, 168:474-85. 10.1111\/bjd.12149","journal-title":"Br J Dermatol"},{"key":"ref182","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1702493","article-title":"Acne vulgaris","volume":"379","author":"Zaenglein AL","year":"2018","unstructured":"Zaenglein AL. Acne vulgaris. N Engl J Med. 2018, 379:1343-52. 10.1056\/NEJMcp1702493","journal-title":"N Engl J Med"},{"key":"ref183","unstructured":"Acne clinical guideline. Accessed. June 5, 2022: https:\/\/www.aad.org\/member\/clinical-quality\/guidelines\/acne."},{"key":"ref184","article-title":"Oily skin: a review of treatment options","volume":"10","author":"Endly DC","year":"2017","unstructured":"Endly DC, Miller RA. Oily skin: a review of treatment options. J Clin Aesthet Dermatol. 2017, 10:49-55.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref185","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14168","article-title":"Acne as an altered dermato-endocrine response problem","volume":"29","author":"Briganti S","year":"2020","unstructured":"Briganti S, Flori E, Mastrofrancesco A, Ottaviani M. Acne as an altered dermato-endocrine response problem. Exp Dermatol. 2020, 29:833-9. 10.1111\/exd.14168","journal-title":"Exp Dermatol"},{"key":"ref186","article-title":"Polycystic ovary syndrome and acne","volume":"15","author":"Chuan SS","year":"2010","unstructured":"Chuan SS, Chang RJ. Polycystic ovary syndrome and acne. Skin Therapy Lett. 2010, 15:1-4.","journal-title":"Skin Therapy Lett"},{"key":"ref187","doi-asserted-by":"publisher","DOI":"10.3390\/nu10081049","article-title":"Dairy intake and acne vulgaris: a systematic review and meta-analysis of 78,529 children, adolescents, and young adults","volume":"10","author":"Juhl CR","year":"2018","unstructured":"Juhl CR, Bergholdt HK, Miller IM, Jemec GB, Kanters JK, Ellervik C. Dairy intake and acne vulgaris: a systematic review and meta-analysis of 78,529 children, adolescents, and young adults. Nutrients. 2018, 10:10.3390\/nu10081049","journal-title":"Nutrients"},{"key":"ref188","doi-asserted-by":"publisher","DOI":"10.12788\/cutis.0057","article-title":"Fighting acne for the fighting forces","volume":"106","author":"Brahe C","year":"2020","unstructured":"Brahe C, Peters K. Fighting acne for the fighting forces. Cutis. 2020, 106:18-22. 10.12788\/cutis.0057","journal-title":"Cutis"},{"key":"ref189","article-title":"Management of keloids and hypertrophic scars","volume":"80","author":"Juckett G","year":"2009","unstructured":"Juckett G,  Hartman-Adams H. Management of keloids and hypertrophic scars. Am Fam Physician. 2009, 80:253-60.","journal-title":"Am Fam Physician"},{"key":"ref190","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000819","article-title":"Keloids and hypertrophic scars: pathophysiology, classification, and treatment","volume":"43","author":"Berman B","year":"2017","unstructured":"Berman B, Maderal A, Raphael B. Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg. 2017, 43:S3-S18. 10.1097\/DSS.0000000000000819","journal-title":"Dermatol Surg"},{"key":"ref191","doi-asserted-by":"publisher","DOI":"10.1111\/wrr.12574","article-title":"Different properties of skin of different body sites: the root of keloid formation?","volume":"25","author":"Butzelaar L","year":"2017","unstructured":"Butzelaar L, Niessen FB, Talhout W, Schooneman DP, Ulrich MM, Beelen RH, Mink van der Molen AB. Different properties of skin of different body sites: the root of keloid formation?. Wound Repair Regen. 2017, 25:758-66. 10.1111\/wrr.12574","journal-title":"Wound Repair Regen"},{"key":"ref192","doi-asserted-by":"publisher","DOI":"10.3109\/2000656X.2012.669184","article-title":"Formation of hypertrophic scars: evolution and susceptibility","volume":"46","author":"Mahdavian Delavary B","year":"2012","unstructured":"Mahdavian Delavary B, van der Veer WM, Ferreira JA, Niessen FB. Formation of hypertrophic scars: evolution and susceptibility. J Plast Surg Hand Surg. 2012, 46:95-101. 10.3109\/2000656X.2012.669184","journal-title":"J Plast Surg Hand Surg"},{"key":"ref193","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00083","article-title":"Current therapeutic approach to hypertrophic scars","volume":"4","author":"Mokos ZB","year":"2017","unstructured":"Mokos ZB, Jovi\u0107 A, Grgurevi\u0107 L, Dumi\u0107-\u010cule I, Kostovi\u0107 K, \u010ceovi\u0107 R, Marinovi\u0107 B. Current therapeutic approach to hypertrophic scars. Front Med (Lausanne). 2017, 4:83. 10.3389\/fmed.2017.00083","journal-title":"Front Med (Lausanne)"},{"key":"ref194","doi-asserted-by":"publisher","DOI":"10.1186\/s41702-020-00063-8","article-title":"Hypertrophic scars and keloids: a review and current treatment modalities","volume":"4","author":"Tripathi S","year":"2020","unstructured":"Tripathi S, Soni K, Agrawal P, Gour V, Mondal R, Soni V. Hypertrophic scars and keloids: a review and current treatment modalities. Biomedical Dermatology. 2020, 4:11. 10.1186\/s41702-020-00063-8","journal-title":"Biomedical Dermatology"},{"key":"ref195","unstructured":"Keloids. diagnosis and treatment. Accessed: June 5, 2022: https:\/\/www.aad.org\/public\/diseases\/a-z\/keloids-treatment."},{"key":"ref196","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S133672","article-title":"Triamcinolone acetonide intralesional injection for the treatment of keloid scars: patient selection and perspectives","volume":"11","author":"Morelli Coppola M","year":"2018","unstructured":"Morelli Coppola M, Salzillo R, Segreto F, Persichetti P. Triamcinolone acetonide intralesional injection for the treatment of keloid scars: patient selection and perspectives. Clin Cosmet Investig Dermatol. 2018, 11:387-96. 10.2147\/CCID.S133672","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref197","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-016-0118-5","article-title":"5-Fluorouracil in the treatment of keloids and hypertrophic scars: a comprehensive review of the literature","volume":"6","author":"Shah VV","year":"2016","unstructured":"Shah VV, Aldahan AS, Mlacker S, Alsaidan M, Samarkandy S, Nouri K. 5-Fluorouracil in the treatment of keloids and hypertrophic scars: a comprehensive review of the literature. Dermatol Ther (Heidelb). 2016, 6:169-83. 10.1007\/s13555-016-0118-5","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref198","article-title":"Topical silicone sheet application in the treatment of hypertrophic scars and keloids","volume":"9","author":"Westra I","year":"2016","unstructured":"Westra I, Pham H, Niessen FB. Topical silicone sheet application in the treatment of hypertrophic scars and keloids. J Clin Aesthet Dermatol. 2016, 9:28-35.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref199","doi-asserted-by":"publisher","DOI":"10.4103\/2141-9248.138040","article-title":"Custom made pressure appliance for presurgical sustained compression of auricular keloid","volume":"4","author":"Rathee M","year":"2014","unstructured":"Rathee M, Kundu R, Tamrakar A. Custom made pressure appliance for presurgical sustained compression of auricular keloid. Ann Med Health Sci Res. 2014, 4:S147-51. 10.4103\/2141-9248.138040","journal-title":"Ann Med Health Sci Res"},{"key":"ref200","doi-asserted-by":"publisher","DOI":"10.1038\/srep40185","article-title":"The effectiveness of pressure therapy (15-25\u2009mmHg) for hypertrophic burn scars: a systematic review and meta-analysis","volume":"7","author":"Ai JW","year":"2017","unstructured":"Ai JW, Liu JT, Pei SD, Liu Y, Li DS, Lin HM, Pei B. The effectiveness of pressure therapy (15-25\u2009mmHg) for hypertrophic burn scars: a systematic review and meta-analysis. Sci Rep. 2017, 7:40185. 10.1038\/srep40185","journal-title":"Sci Rep"},{"key":"ref201","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1993.01680300074011","article-title":"Outcomes of cryosurgery in keloids and hypertrophic scars: a prospective consecutive trial of case series","volume":"129","author":"Zouboulis CC","year":"1993","unstructured":"Zouboulis CC, Blume U, B\u00fcttner P, Orfanos CE. Outcomes of cryosurgery in keloids and hypertrophic scars: a prospective consecutive trial of case series. Arch Dermatol. 1993, 129:1146-51.","journal-title":"Arch Dermatol"},{"key":"ref202","doi-asserted-by":"publisher","DOI":"10.1177\/2059513117702162","article-title":"Intralesional cryotherapy for hypertrophic scars and keloids: a review","volume":"3","author":"O'Boyle CP","year":"2017","unstructured":"O'Boyle CP, Shayan-Arani H, Hamada MW. Intralesional cryotherapy for hypertrophic scars and keloids: a review. Scars Burn Heal. 2017, 3:10.1177\/2059513117702162","journal-title":"Scars Burn Heal"},{"key":"ref203","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S35252","article-title":"Management of keloids and hypertrophic scars: current and emerging options","volume":"6","author":"Gauglitz GG","year":"2013","unstructured":"Gauglitz GG. Management of keloids and hypertrophic scars: current and emerging options. Clin Cosmet Investig Dermatol. 2013, 6:103-14. 10.2147\/CCID.S35252","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref204","unstructured":"Medical standards for military service. appointment, enlistment, or induction. Accessed: December 22, 2022: https:\/\/www.esd.whs.mil\/Portals\/54\/Documents\/DD\/issuances\/dodi\/613003_vol1.PDF?ver=7fhqacc0jGX_R9_1iexudA%3D%3D."},{"key":"ref205","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S137296","article-title":"Traction alopecia: the root of the problem","volume":"11","author":"Billero V","year":"2018","unstructured":"Billero V, Miteva M. Traction alopecia: the root of the problem. Clin Cosmet Investig Dermatol. 2018, 11:149-59. 10.2147\/CCID.S137296","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref206","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usab274","article-title":"Free the bun: prevalence of alopecia among active duty service women, fiscal years 2010-2019","author":"Korona-Bailey J","year":"2021","unstructured":"Korona-Bailey J, Banaag A, Nguyen DR, Pasieka H, Koehlmoos TP. Free the bun: prevalence of alopecia among active duty service women, fiscal years 2010-2019. Mil Med. 2021, usab274. 10.1093\/milmed\/usab274","journal-title":"Mil Med"},{"key":"ref207","article-title":"Traction folliculitis: an underreported entity","volume":"79","author":"Fox GN","year":"2007","unstructured":"Fox GN, Stausmire JM, Mehregan DR. Traction folliculitis: an underreported entity. Cutis. 2007, 79:26-30.","journal-title":"Cutis"},{"key":"ref208","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.05.036","article-title":"Determinants of marginal traction alopecia in African girls and women","volume":"59","author":"Khumalo NP","year":"2008","unstructured":"Khumalo NP, Jessop S, Gumedze F, Ehrlich R. Determinants of marginal traction alopecia in African girls and women. J Am Acad Dermatol. 2008, 59:432-8. 10.1016\/j.jaad.2008.05.036","journal-title":"J Am Acad Dermatol"},{"key":"ref209","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08848.x","article-title":"Cicatricial marginal alopecia: is it all traction?","volume":"160","author":"Goldberg LJ","year":"2009","unstructured":"Goldberg LJ. Cicatricial marginal alopecia: is it all traction?. Br J Dermatol. 2009, 160:62-8. 10.1111\/j.1365-2133.2008.08848.x","journal-title":"Br J Dermatol"},{"key":"ref210","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12707","article-title":"Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five C's of oral therapy","volume":"31","author":"Beach RA","year":"2018","unstructured":"Beach RA. Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five C's of oral therapy. Dermatol Ther. 2018, 31:e12707. 10.1111\/dth.12707","journal-title":"Dermatol Ther"},{"key":"ref211","doi-asserted-by":"crossref","DOI":"10.5070\/D325M840MZ","article-title":"The \"Fringe Sign\" - a useful clinical finding in traction alopecia of the marginal hair line","volume":"17","author":"Samrao A","year":"2011","unstructured":"Samrao A, Price VH, Zedek D, Mirmirani P. The \"Fringe Sign\" - a useful clinical finding in traction alopecia of the marginal hair line. Dermatol Online J. 2011, 17:1.","journal-title":"Dermatol Online J"},{"key":"ref212","doi-asserted-by":"publisher","DOI":"10.1111\/j.1396-0296.2004.04017.x","article-title":"Medical and surgical therapies for alopecias in black women","volume":"17","author":"Callender VD","year":"2004","unstructured":"Callender VD, McMichael AJ, Cohen GF. Medical and surgical therapies for alopecias in black women. Dermatol Ther. 2004, 17:164-76. 10.1111\/j.1396-0296.2004.04017.x","journal-title":"Dermatol Ther"},{"key":"ref213","doi-asserted-by":"publisher","DOI":"10.1016\/j.sder.2009.04.004","article-title":"Approach to hair loss in women of color","volume":"28","author":"Fu JM","year":"2009","unstructured":"Fu JM, Price VH. Approach to hair loss in women of color. Semin Cutan Med Surg. 2009, 28:109-14. 10.1016\/j.sder.2009.04.004","journal-title":"Semin Cutan Med Surg"},{"key":"ref214","doi-asserted-by":"publisher","DOI":"10.12788\/cutis.0296","article-title":"From buns to braids and ponytails: entering a new era of female military hair-grooming standards","volume":"108","author":"May Franklin JM","year":"2021","unstructured":"May Franklin JM, Wohltmann WE, Wong EB. From buns to braids and ponytails: entering a new era of female military hair-grooming standards. Cutis. 2021, 108:31-5. 10.12788\/cutis.0296","journal-title":"Cutis"},{"key":"ref215","unstructured":"United States army appearance and grooming modifications. (2021). https.\/\/armyreup.s3.amazonaws.com\/site\/wp-content\/uploads\/2021\/02\/26142503\/ALARACT_015_2021_NEW_GROOMING_STANDARDS.pdf."},{"key":"ref216","unstructured":"Dress and personal appearance of United States air force and United States space force personnel. (2020). Accessed. June 5, 2022: https:\/\/static.e-publishing.af.mil\/production\/1\/af_a1\/publication\/dafi36-2903\/dafi36-2903.pdf."},{"key":"ref217","unstructured":"Chapter two. grooming standards\u20142201 - personal appearance. (2020). Accessed: June 5, 2022: https:\/\/www.mynavyhr.navy.mil\/References\/US-Navy-Uniforms\/Uniform-Regulations\/Chapter-2\/2201-Personal-Appearance\/."},{"key":"ref218","doi-asserted-by":"publisher","DOI":"10.1080\/08995605.2022.2058302","article-title":"Body image and psychosocial well-being among UK military personnel and veterans who sustained appearance-altering conflict injuries","author":"Keeling M","year":"2022","unstructured":"Keeling M, Williamson H, Williams VS, Kiff J, Evans S, Murphy D, Harcourt D. Body image and psychosocial well-being among UK military personnel and veterans who sustained appearance-altering conflict injuries. Mil Psychol. 2022, 1-15. 10.1080\/08995605.2022.2058302","journal-title":"Mil Psychol"},{"key":"ref219","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.02.067","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part I: diagnosis, evaluation, and the use of complementary and procedural management","volume":"81","author":"Alikhan A","year":"2019","unstructured":"Alikhan A, Sayed C, Alavi A, et al.. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part I: diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019, 81:76-90. 10.1016\/j.jaad.2019.02.067","journal-title":"J Am Acad Dermatol"},{"key":"ref220","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-014-0105-5","article-title":"Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study","volume":"16","author":"Alavi A","year":"2015","unstructured":"Alavi A, Anooshirvani N, Kim WB, Coutts P, Sibbald RG. Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study. Am J Clin Dermatol. 2015, 16:61-5. 10.1007\/s40257-014-0105-5","journal-title":"Am J Clin Dermatol"},{"key":"ref221","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2013-131994","article-title":"Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease","volume":"90","author":"Dufour DN","year":"2014","unstructured":"Dufour DN, Emtestam L, Jemec GB. Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease. Postgrad Med J. 2014, 90:216-21. 10.1136\/postgradmedj-2013-131994","journal-title":"Postgrad Med J"},{"key":"ref222","doi-asserted-by":"publisher","DOI":"10.12788\/cutis.0095","article-title":"Hidradenitis suppurativa in the military","volume":"106","author":"Godiwalla RY","year":"2020","unstructured":"Godiwalla RY, Storie EB, Winn AE. Hidradenitis suppurativa in the military. Cutis. 2020, 106:181-4. 10.12788\/cutis.0095","journal-title":"Cutis"},{"key":"ref223","unstructured":"Hidradenitis suppurativa. management. Accessed: June 5, 2022: https:\/\/www.uptodate.com\/contents\/hidradenitis-suppurativa-management."},{"key":"ref224","unstructured":"Hidradenitis suppurativa. diagnosis and treatment. (2022). Accessed: June 5, 2022: https:\/\/www.aad.org\/public\/diseases\/a-z\/hidradenitis-suppurativa-treatment."},{"key":"ref225","doi-asserted-by":"publisher","DOI":"10.5114\/reum.2018.80709","article-title":"Hidradenitis suppurativa - known and unknown disease","volume":"56","author":"Wieczorek M","year":"2018","unstructured":"Wieczorek M, Walecka I. Hidradenitis suppurativa - known and unknown disease. Reumatologia. 2018, 56:337-9. 10.5114\/reum.2018.80709","journal-title":"Reumatologia"},{"key":"ref226","unstructured":"Case definitions\u2020 for use in the 2022 mpox response. (2022). Accessed. August 12, 2022: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/case-definition.html."},{"key":"ref227","unstructured":"Human monkeypox -- Kasai oriental, Zaire, 1996-1997 . (1997). Accessed. August 12, 2022: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00048673.htm."},{"key":"ref228","unstructured":"Number of monkeypox cases in the military climbs tenfold in less than 4 weeks. (2022). Accessed. August 12, 2022: https:\/\/www.military.com\/daily-news\/2022\/08\/05\/number-of-monkeypox-cases-military-climbs-tenfold-less-4-weeks.html."},{"key":"ref229","unstructured":"CDC monkeypox response. transmission. (2022). Accessed: August 12, 2022: https:\/\/www.cdc.gov\/media\/releases\/2022\/0509-monkeypox-transmission.html."},{"key":"ref230","unstructured":"Mpox (monkeypox). background information. (2022). Accessed: August 12, 2022: https:\/\/www.gov.uk\/guidance\/monkeypox."},{"key":"ref231","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix260","article-title":"Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo","volume":"216","author":"Mbala PK","year":"2017","unstructured":"Mbala PK, Huggins JW, Riu-Rovira T, et al.. Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo. J Infect Dis. 2017, 216:824-8. 10.1093\/infdis\/jix260","journal-title":"J Infect Dis"},{"key":"ref232","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.27.2200471","article-title":"Monkeypox outbreak predominantly affecting men who have sex with men, Madrid, Spain, 26 April to 16 June 2022","volume":"27","author":"I\u00f1igo Mart\u00ednez J","year":"2022","unstructured":"I\u00f1igo Mart\u00ednez J, Gil Montalb\u00e1n E, Jim\u00e9nez Bueno S, et al.. Monkeypox outbreak predominantly affecting men who have sex with men, Madrid, Spain, 26 April to 16 June 2022. Euro Surveill. 2022, 27:2200471. 10.2807\/1560-7917.ES.2022.27.27.2200471","journal-title":"Euro Surveill"},{"key":"ref233","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries - April-June 2022","volume":"387","author":"Thornhill JP","year":"2022","unstructured":"Thornhill JP, Barkati S, Walmsley S, et al.. Monkeypox virus infection in humans across 16 countries - April-June 2022. N Engl J Med. 2022, 387:679-91. 10.1056\/NEJMoa2207323","journal-title":"N Engl J Med"},{"key":"ref234","unstructured":"Monkeypox. (2022). Accessed. August 12, 2022: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/monkeypox."},{"key":"ref235","unstructured":"Smallpox vaccination and adverse reactions. guidance for clinicians. (2003). Accessed: August 12, 2022: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5204a1.htm."},{"key":"ref236","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2020.94834","article-title":"Teledermatology: idea, benefits and risks of modern age - a systematic review based on melanoma","volume":"37","author":"Pala P","year":"2020","unstructured":"Pala P, Bergler-Czop BS, Gwi\u017cd\u017c JM. Teledermatology: idea, benefits and risks of modern age - a systematic review based on melanoma. Postepy Dermatol Alergol. 2020, 37:159-67. 10.5114\/ada.2020.94834","journal-title":"Postepy Dermatol Alergol"},{"key":"ref237","article-title":"Teledermatology in the US military: a historic foundation for current and future applications","volume":"101","author":"Hwang J","year":"2018","unstructured":"Hwang J, Kakimoto C. Teledermatology in the US military: a historic foundation for current and future applications. Cutis. 2018, 101:335-7.","journal-title":"Cutis"},{"key":"ref238","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14341","article-title":"Telemedicine in dermatology: findings and experiences worldwide - a systematic literature review","volume":"32","author":"Trettel A","year":"2018","unstructured":"Trettel A, Eissing L, Augustin M. Telemedicine in dermatology: findings and experiences worldwide - a systematic literature review. J Eur Acad Dermatol Venereol. 2018, 32:215-24. 10.1111\/jdv.14341","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref239","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13605","article-title":"Position paper: telemedicine in occupational dermatology - current status and perspectives","volume":"16","author":"Elsner P","year":"2018","unstructured":"Elsner P, Bauer A, Diepgen TL, et al.. Position paper: telemedicine in occupational dermatology - current status and perspectives. J Dtsch Dermatol Ges. 2018, 16:969-74. 10.1111\/ddg.13605","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref240","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2007.0016","article-title":"Systematic human factors evaluation of a teledermatology system within the U.S. military","volume":"14","author":"Stronge AJ","year":"2008","unstructured":"Stronge AJ, Nichols T, Rogers WA, Fisk AD. Systematic human factors evaluation of a teledermatology system within the U.S. military. Telemedicine and e-Health. 2008, 14:25-34. 10.1089\/tmj.2007.0016","journal-title":"Telemedicine and e-Health"},{"key":"ref241","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usz110","article-title":"The burden of skin disease on deployed servicemembers","volume":"184","author":"Gregory JF","year":"2019","unstructured":"Gregory JF, Taylor EA, Liu YE, Love TV, Raiciulescu S, Meyerle JH. The burden of skin disease on deployed servicemembers. Mil Med. 2019, 184:889-93. 10.1093\/milmed\/usz110","journal-title":"Mil Med"},{"key":"ref242","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.110","article-title":"Teledermatology from a combat zone","volume":"146","author":"Henning JS","year":"2010","unstructured":"Henning JS, Wohltmann W, Hivnor C. Teledermatology from a combat zone. Arch Dermatol. 2010, 146:676-7. 10.1001\/archdermatol.2010.110","journal-title":"Arch Dermatol"},{"key":"ref243","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.07.061","article-title":"Teledermatology: from historical perspective to emerging techniques of the modern era: part I: History, rationale, and current practice","volume":"72","author":"Coates SJ","year":"2015","unstructured":"Coates SJ, Kvedar J, Granstein RD. Teledermatology: from historical perspective to emerging techniques of the modern era: part I: History, rationale, and current practice. J Am Acad Dermatol. 2015, 72:563-76. 10.1016\/j.jaad.2014.07.061","journal-title":"J Am Acad Dermatol"},{"key":"ref244","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usz479","article-title":"Synchronous teledermoscopy in military treatment facilities","volume":"185","author":"Day WG","year":"2020","unstructured":"Day WG, Shrivastava V, Roman JW. Synchronous teledermoscopy in military treatment facilities. Mil Med. 2020, 185:e1334-7. 10.1093\/milmed\/usz479","journal-title":"Mil Med"},{"key":"ref245","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02427.x","article-title":"Teledermatology research review","volume":"45","author":"Whited JD","year":"2006","unstructured":"Whited JD. Teledermatology research review. Int J Dermatol. 2006, 45:220-9. 10.1111\/j.1365-4632.2004.02427.x","journal-title":"Int J Dermatol"},{"key":"ref246","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.08.026","article-title":"Teledermatology for diagnosis and management of skin conditions: a systematic review","volume":"64","author":"Warshaw EM","year":"2011","unstructured":"Warshaw EM, Hillman YJ, Greer NL, Hagel EM, MacDonald R, Rutks IR, Wilt TJ. Teledermatology for diagnosis and management of skin conditions: a systematic review. J Am Acad Dermatol. 2011, 64:759-72. 10.1016\/j.jaad.2010.08.026","journal-title":"J Am Acad Dermatol"},{"key":"ref247","article-title":"Defense health agency (DHA) update on virtual health (VH) for defense health board","author":"Reynolds N","year":"2022","unstructured":"Reynolds N. Defense health agency (DHA) update on virtual health (VH) for defense health board. Department of Defense, USA; 2022."},{"key":"ref248","unstructured":"PATH & HELP to transition to GTP. (2020). Accessed. August 14, 2022: https:\/\/path.tamc.amedd.army.mil\/path\/pdf\/GTP_Transition2.pdf."},{"key":"ref249","doi-asserted-by":"crossref","unstructured":"GTP training 101. (2022). Accessed. August 14, 2022: https:\/\/help.nmcp.med.navy.mil\/path\/help\/help.htm.","DOI":"10.12968\/nuwa.2022.5.14"},{"key":"ref250","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100641","article-title":"Teledermatology reduces dermatology referrals and improves access to specialists","volume":"29","author":"Giavina-Bianchi M","year":"2020","unstructured":"Giavina-Bianchi M, Santos AP, Cordioli E. Teledermatology reduces dermatology referrals and improves access to specialists. EClinicalMedicine. 2020, 29:100641. 10.1016\/j.eclinm.2020.100641","journal-title":"EClinicalMedicine"},{"key":"ref251","article-title":"Combat dermatology: the role of the deployed army dermatologist","volume":"103","author":"Durso TA","year":"2019","unstructured":"Durso TA, Iddins BO, Miletta NR. Combat dermatology: the role of the deployed army dermatologist. Cutis. 2019, 103:21-4.","journal-title":"Cutis"},{"key":"ref252","doi-asserted-by":"publisher","DOI":"10.7205\/milmed.169.6.444","article-title":"Operational dermatology","volume":"169","author":"Schissel DJ","year":"2004","unstructured":"Schissel DJ, Wilde JL. Operational dermatology. Mil Med. 2004, 169:444-7. 10.7205\/milmed.169.6.444","journal-title":"Mil Med"},{"key":"ref253","doi-asserted-by":"publisher","DOI":"10.12788\/cutis.0541","article-title":"Cutaneous body image: how the mental health benefits of treating dermatologic disease support military readiness in service members","volume":"109","author":"Brahe C","year":"2022","unstructured":"Brahe C. Cutaneous body image: how the mental health benefits of treating dermatologic disease support military readiness in service members. Cutis. 2022, 109:310-13. 10.12788\/cutis.0541","journal-title":"Cutis"},{"key":"ref254","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00351-5","article-title":"The validity of cutaneous body image as a construct and as a mediator of the relationship between cutaneous disease and mental health","volume":"10","author":"Hinkley SB","year":"2020","unstructured":"Hinkley SB, Holub SC, Menter A. The validity of cutaneous body image as a construct and as a mediator of the relationship between cutaneous disease and mental health. Dermatol Ther (Heidelb). 2020, 10:203-11. 10.1007\/s13555-020-00351-5","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref255","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usy296","article-title":"Suicide in the military: understanding rates and risk factors across the United States' armed forces","volume":"184","author":"Pruitt LD","year":"2019","unstructured":"Pruitt LD, Smolenski DJ, Bush NE, Tucker J, Issa F, Hoyt TV, Reger MA. Suicide in the military: understanding rates and risk factors across the United States' armed forces. Mil Med. 2019, 184:432-7. 10.1093\/milmed\/usy296","journal-title":"Mil Med"},{"key":"ref256","doi-asserted-by":"publisher","DOI":"10.3390\/dermatopathology9030027","article-title":"The impact of COVID-19 pandemic on dermatological conditions: a novel, comprehensive review","volume":"9","author":"Pendlebury GA","year":"2022","unstructured":"Pendlebury GA, Oro P, Haynes W, Merideth D, Bartling S, Bongiorno MA. The impact of COVID-19 pandemic on dermatological conditions: a novel, comprehensive review. Dermatopathology (Basel). 2022, 9:212-43. 10.3390\/dermatopathology9030027","journal-title":"Dermatopathology (Basel)"},{"key":"ref257","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2021.05.013","article-title":"Dermatology COVID-19 registries: updates and future directions","volume":"39","author":"Freeman EE","year":"2021","unstructured":"Freeman EE, Chamberlin GC, McMahon DE, et al.. Dermatology COVID-19 registries: updates and future directions. Dermatol Clin. 2021, 39:575-85. 10.1016\/j.det.2021.05.013","journal-title":"Dermatol Clin"},{"key":"ref258","unstructured":"Monkeypox resource center. Accessed. July 13, 2022: https:\/\/www.aad.org\/member\/clinical-quality\/clinical-care\/monkeypox."},{"key":"ref259","unstructured":"As monkeypox outbreak grows nationally, cases remain rare in US military. (2022). Accessed. July 13, 2022: https:\/\/www.military.com\/daily-news\/2022\/07\/11\/monkeypox-outbreak-grows-nationally-cases-remain-rare-us-military.html."},{"key":"ref260","unstructured":"Mpox. (2022). Accessed. July 13, 2022: https:\/\/www.med.navy.mil\/Navy-Marine-Corps-Public-Health-Center\/Preventive-Medicine\/Program-and-Policy-Support\/Monkey...."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/117200-relevant-dermatoses-among-us-military-service-members-an-operational-review-of-management-strategies-and-telemedicine-utilization","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:53:34Z","timestamp":1707508414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/117200-relevant-dermatoses-among-us-military-service-members-an-operational-review-of-management-strategies-and-telemedicine-utilization"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,2]]},"references-count":260,"URL":"https:\/\/doi.org\/10.7759\/cureus.33274","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,2]]}}}